Home Cart Sign in  
Chemical Structure| 59820-43-8 Chemical Structure| 59820-43-8

Structure of 59820-43-8

Chemical Structure| 59820-43-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 59820-43-8 ]

CAS No. :59820-43-8
Formula : C10H14N2O5
M.W : 242.23
SMILES Code : C1=C(C=C(C(=C1)NCCO)OCCO)[N+]([O-])=O
MDL No. :MFCD03265655
InChI Key :PNENOUKIPPERMY-UHFFFAOYSA-N
Pubchem ID :62158

Safety of [ 59820-43-8 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 59820-43-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 17
Num. arom. heavy atoms 6
Fraction Csp3 0.4
Num. rotatable bonds 7
Num. H-bond acceptors 5.0
Num. H-bond donors 3.0
Molar Refractivity 63.0
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

107.54 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.5
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.34
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.18
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.61
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.09
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.06

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.36
Solubility 10.7 mg/ml ; 0.0441 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.16
Solubility 1.67 mg/ml ; 0.00688 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.05
Solubility 2.18 mg/ml ; 0.00899 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.54 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.51
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 59820-43-8 ]

Aryls

Chemical Structure| 761440-26-0

A140285 [761440-26-0]

1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine

Similarity: 0.84

Chemical Structure| 67827-72-9

A183544 [67827-72-9]

2-Methoxy-5-nitroaniline hydrochloride

Similarity: 0.81

Chemical Structure| 265654-77-1

A519295 [265654-77-1]

1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine

Similarity: 0.81

Chemical Structure| 22483-40-5

A123582 [22483-40-5]

1-(2-Methoxyethoxy)-4-nitrobenzene

Similarity: 0.81

Chemical Structure| 1373253-27-0

A976614 [1373253-27-0]

3-(3-Nitrophenoxy)azetidine hydrochloride

Similarity: 0.81

Ethers

Chemical Structure| 761440-26-0

A140285 [761440-26-0]

1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine

Similarity: 0.84

Chemical Structure| 67827-72-9

A183544 [67827-72-9]

2-Methoxy-5-nitroaniline hydrochloride

Similarity: 0.81

Chemical Structure| 265654-77-1

A519295 [265654-77-1]

1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine

Similarity: 0.81

Chemical Structure| 22483-40-5

A123582 [22483-40-5]

1-(2-Methoxyethoxy)-4-nitrobenzene

Similarity: 0.81

Chemical Structure| 1373253-27-0

A976614 [1373253-27-0]

3-(3-Nitrophenoxy)azetidine hydrochloride

Similarity: 0.81

Alcohols

Chemical Structure| 26021-57-8

A106372 [26021-57-8]

3,4-Dihydro-2H-benzo[b][1,4]oxazin-6-ol

Similarity: 0.75

Chemical Structure| 83763-47-7

A119412 [83763-47-7]

2-((3-Amino-4-methoxyphenyl)amino)ethanol

Similarity: 0.73

Chemical Structure| 92952-81-3

A341372 [92952-81-3]

4-((3-Hydroxypropyl)amino)-3-nitrophenol

Similarity: 0.72

Chemical Structure| 1016-58-6

A159638 [1016-58-6]

(4,5-Dimethoxy-2-nitrophenyl)methanol

Similarity: 0.69

Chemical Structure| 369-07-3

A444605 [369-07-3]

(2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triol

Similarity: 0.67

Amines

Chemical Structure| 67827-72-9

A183544 [67827-72-9]

2-Methoxy-5-nitroaniline hydrochloride

Similarity: 0.81

Chemical Structure| 577-72-0

A201413 [577-72-0]

4-Methoxy-3-nitroaniline

Similarity: 0.80

Chemical Structure| 115287-37-1

A124477 [115287-37-1]

N-Methyl-2-(4-nitrophenoxy)-N-[2-(4-nitrophenyl)ethyl]ethanamine

Similarity: 0.74

Chemical Structure| 1552-17-6

A400744 [1552-17-6]

2-Nitro-5-phenoxyaniline

Similarity: 0.74

Chemical Structure| 16133-49-6

A137083 [16133-49-6]

5-Methoxy-2-nitrophenylamine

Similarity: 0.74

Nitroes

Chemical Structure| 120711-81-1

A305663 [120711-81-1]

7-Nitro-3,4-dihydro-2H-1,4-benzooxazine

Similarity: 0.87

Chemical Structure| 761440-26-0

A140285 [761440-26-0]

1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine

Similarity: 0.84

Chemical Structure| 67827-72-9

A183544 [67827-72-9]

2-Methoxy-5-nitroaniline hydrochloride

Similarity: 0.81

Chemical Structure| 265654-77-1

A519295 [265654-77-1]

1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine

Similarity: 0.81

Chemical Structure| 22483-40-5

A123582 [22483-40-5]

1-(2-Methoxyethoxy)-4-nitrobenzene

Similarity: 0.81